APIs and intermediates

In addition to its APIs and intermediates business, which focuses on generics in focus areas such as lifestyle diseases (hypertension and hyperlipidemia drugs), psychiatric and neurological diseases (antidepressants, antipsychotics, antiepileptics), eye drops, Tokuyama is also working on developing original and novel processes to produce high-purity, economically viable pharmaceutical ingredients.

Special characteristics

  • At our Kashima Factory, we produce high-quality products based on facilities and management practices that are compliant with GMP standards.
  • Tokuyama can adjust production schedules according to customers' demand because it owns a wide array of reactor vessels ranging from 10 liters to 5,000 liters.
  • Through its operations in optical materials and electronic materials, Tokuyama has developed technologies for organic synthesis, crystallization and analysis that can be applied in a broad range of fields.
  • Tokuyama can efficiently produce pharmaceutical ingredients of exceptionally high purity by means of exclusive facilities such as columns filled with resins and active carbon, that enables to apply purification operations tailored to the property of each chemical compound to production processes.

Inquiries Concerning Products

APIs & Intermediates Dept.

Please click here for additional information on our products

Related products